<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05114057</url>
  </required_header>
  <id_info>
    <org_study_id>CIN002 - Taking Focus 3</org_study_id>
    <nct_id>NCT05114057</nct_id>
  </id_info>
  <brief_title>Use of NGAL for Fluid Dosing and CRRT Initiation in Pediatric and Neonatal AKI</brief_title>
  <acronym>Taking Focus 2</acronym>
  <official_title>Use of NGAL to Optimize Fluid Dosing, CRRT Initiation and Discontinuation in Critically Ill Children and Neonates With Acute Kidney Injury</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Hospital Medical Center, Cincinnati</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Children's Hospital Medical Center, Cincinnati</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will follow patients admitted to the PICU with sepsis, NICU with sepsis or after&#xD;
      abdominal surgery, or CICU who are identified as being at risk for developing acute kidney&#xD;
      injury. The investigators will use risk-stratification, biomarker testing, and a functional&#xD;
      assessment to predict children and neonates who will become fluid overloaded and develop&#xD;
      severe acute kidney injury.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the pediatric population, acute kidney injury (AKI) is commonly observed in critically ill&#xD;
      patients. At this time, there are no standardized care pathways that begin at identifying&#xD;
      patients at risk for developing AKI and progress through to early recognition and treatment.&#xD;
      Through previous work, the investigators have integrated a risk-stratification tool (renal&#xD;
      angina index or RAI) and a urine biomarker (NGAL) to try to identify PICU patients at risk&#xD;
      versus not at-risk for developing AKI. Through this study, the investigators will tailor the&#xD;
      RAI to the septic population in the PICU, create a new NICU RAI, and investigate the utility&#xD;
      of the CICU specific RAI in a prospective population. Biomarker testing will be used to&#xD;
      further risk-stratify those patients deemed at highest risk through the RAI.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2022</start_date>
  <completion_date type="Anticipated">July 1, 2028</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2027</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical Decision Support Performance</measure>
    <time_frame>Days 2-4 after ICU admission</time_frame>
    <description>Accuracy of the risk stratification and biomarker testing to rule out Acute Kidney Injury at ICU Days 2-4 as measured by the negative predictive value (NPV)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of Clinical Decision Support Completion</measure>
    <time_frame>48 hours</time_frame>
    <description>Time to complete the risk stratification and biomarker testing is less than 48 hours</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">1380</enrollment>
  <condition>Acute Kidney Injury</condition>
  <condition>Acute Kidney Injury Due to Sepsis</condition>
  <condition>Neonatal Sepsis</condition>
  <arm_group>
    <arm_group_label>PICU Patients</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Prospectively enrolled patients admitted to the PICU will be assessed by the RAI calibration for sepsis in the PICU and including additional risk factors.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CICU Patients</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Prospectively enrolled patients admitted to the CICU will be assessed by the RAI calibration specific to the CICU, especially post cardiac bypass</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NICU Patients</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Prospectively enrolled patients admitted to the NICU will be assessed by the RAI calibration for neonatal patients with sepsis or post abdominal surgeries</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Renal Angina Index (RAI)</intervention_name>
    <description>Risk-stratification tool using measures of risk and presence of injury to predict Acute Kidney Injury</description>
    <arm_group_label>CICU Patients</arm_group_label>
    <arm_group_label>NICU Patients</arm_group_label>
    <arm_group_label>PICU Patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Admitted to the Pediatric Intensive Care Unit (PICU), Cardiac Intensive Care Unit&#xD;
             (CICU), or Neonatal Intensive Care Unit (NICU) at participating institution&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Baseline Chronic Kidney Disease (CKD) Stage IV or V (estimated GFR &lt;60 mL/min/1.736m2)&#xD;
&#xD;
          -  History of kidney transplant within the previous 90 days&#xD;
&#xD;
          -  Ongoing AKI or Acute Kidney Disease (AKD) at ICU admission requiring renal replacement&#xD;
             therapy initiated prior to ICU admission&#xD;
&#xD;
          -  Acute DNR order or clinical team is not committed to escalating medical care&#xD;
&#xD;
          -  Anticipated to require intensive care for less than 48 hours&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>25 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stuart L Goldstein, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital Medical Center, Cincinnati</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kelli A Krallman, RN, BSN, MS</last_name>
    <phone>513-636-4837</phone>
    <email>kelli.krallman@cchmc.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cincinnati Children's Hospital Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45229</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Kelli A Krallman, RN, BSN, MS</last_name>
      <email>kelli.krallman@cchmc.org</email>
    </contact>
    <investigator>
      <last_name>Stuart L Goldstein, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Katja Gist, DO</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cara Slagle, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Natalja Stanski, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 20, 2021</study_first_submitted>
  <study_first_submitted_qc>October 28, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 9, 2021</study_first_posted>
  <last_update_submitted>November 10, 2021</last_update_submitted>
  <last_update_submitted_qc>November 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Renal Angina Index</keyword>
  <keyword>NGAL</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
    <mesh_term>Neonatal Sepsis</mesh_term>
    <mesh_term>Acute Kidney Injury</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

